Guardant Health
GH
#3339
Rank
C$4.91 B
Marketcap
$39.79
Share price
0.07%
Change (1 day)
33.62%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of June 2024 : C$1.86 Billion

According to Guardant Health 's latest financial reports the company's total debt is C$1.86 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$1.79 B-3.36%
2022-12-31C$1.85 B6.13%
2021-12-31C$1.75 B60.69%
2020-12-31C$1.08 B1965.09%
2019-12-31C$52.75 M
2018-12-31N/A-100%
2017-12-31C$0.82 M-96.38%
2016-12-31C$22.89 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$0.60 B-67.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.24 B-33.50%๐Ÿ‡บ๐Ÿ‡ธ USA